Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Marksans Pharma Limited (IN:MARKSANS)

:MARKSANS

MARKSANS

Marksans Pharma Limited

RESEARCH TOOLSreports

Marksans Pharma Limited (MARKSANS) Ratios

Compare

6 Followers

Marksans Pharma Limited Ratios

IN:MARKSANS's free cash flow for Q2 2026 was ₹0.57. For the 2026 fiscal year, IN:MARKSANS's free cash flow was decreased by ₹ and operating cash flow was ₹0.19. See a summary of the company’s cash flow.

Ratios	TTM	Mar 25	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	5.18	4.62	4.78	4.91	3.37
Quick Ratio	3.08	2.85	3.19	3.49	2.18
Cash Ratio	1.06	1.04	1.03	1.12	0.97
Solvency Ratio	0.63	0.62	0.65	0.75	0.55
Operating Cash Flow Ratio	0.17	0.43	0.59	0.70	0.28
Short-Term Operating Cash Flow Coverage	3.22	8.95	7.92	5.71	2.40
Net Current Asset Value	₹ 16.26B	₹ 14.54B	₹ 12.67B	₹ 12.50B	₹ 7.84B
Leverage Ratios
Debt-to-Assets Ratio	0.10	0.10	0.09	0.06	0.07
Debt-to-Equity Ratio	0.12	0.13	0.12	0.07	0.09
Debt-to-Capital Ratio	0.11	0.12	0.11	0.07	0.08
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.28	1.31	1.30	1.26	1.36
Debt Service Coverage Ratio	10.35	11.72	9.94	6.43	4.83
Interest Coverage Ratio	29.04	96.81	34.59	32.85	61.21
Debt to Market Cap	<0.01	<0.01	<0.01	0.01	0.02
Interest Debt Per Share	7.80	7.36	5.63	3.18	2.91
Net Debt to EBITDA	-0.26	-0.33	-0.31	-0.65	-0.78
Profitability Margins
Gross Profit Margin	51.91%	56.39%	50.67%	50.25%	49.46%
EBIT Margin	17.17%	16.98%	19.97%	18.72%	17.29%
EBITDA Margin	20.57%	20.16%	23.38%	21.52%	20.32%
Operating Profit Margin	22.01%	43.04%	17.80%	16.19%	34.93%
Pretax Profit Margin	17.00%	19.21%	19.45%	18.23%	16.72%
Net Profit Margin	12.85%	14.51%	14.41%	14.38%	12.47%
Continuous Operations Profit Margin	12.90%	14.59%	14.46%	14.33%	12.62%
Net Income Per EBT	75.59%	75.52%	74.07%	78.87%	74.57%
EBT Per EBIT	77.25%	44.65%	109.30%	112.62%	47.88%
Return on Assets (ROA)	10.47%	11.75%	11.70%	12.16%	11.25%
Return on Equity (ROE)	14.49%	15.43%	15.19%	15.26%	15.35%
Return on Capital Employed (ROCE)	20.65%	40.86%	16.91%	16.21%	40.27%
Return on Invested Capital (ROIC)	15.34%	30.38%	12.29%	12.36%	28.84%
Return on Tangible Assets	10.90%	12.17%	12.17%	12.80%	11.90%
Earnings Yield	4.85%	3.78%	4.38%	9.11%	9.91%
Efficiency Ratios
Receivables Turnover	4.65	4.84	4.74	4.41	3.74
Payables Turnover	4.73	3.74	4.00	4.00	3.74
Inventory Turnover	1.41	1.35	1.74	1.90	1.76
Fixed Asset Turnover	3.04	2.93	3.14	4.79	4.32
Asset Turnover	0.81	0.81	0.81	0.85	0.90
Working Capital Turnover Ratio	2.95	1.64	1.55	1.70	2.04
Cash Conversion Cycle	260.02	247.72	195.76	183.40	207.16
Days of Sales Outstanding	78.53	75.45	76.93	82.73	97.68
Days of Inventory Outstanding	258.60	269.83	210.00	192.03	207.11
Days of Payables Outstanding	77.11	97.56	91.17	91.35	97.63
Operating Cycle	337.13	345.28	286.93	274.76	304.79
Cash Flow Ratios
Operating Cash Flow Per Share	1.66	4.56	5.08	5.72	2.42
Free Cash Flow Per Share	0.04	0.74	0.48	4.42	1.29
CapEx Per Share	1.62	3.82	4.61	1.29	1.13
Free Cash Flow to Operating Cash Flow	0.03	0.16	0.09	0.77	0.53
Dividend Paid and CapEx Coverage Ratio	0.69	1.03	1.00	3.72	1.74
Capital Expenditure Coverage Ratio	1.03	1.20	1.10	4.43	2.14
Operating Cash Flow Coverage Ratio	0.23	0.64	0.94	1.93	0.90
Operating Cash Flow to Sales Ratio	0.03	0.08	0.11	0.13	0.07
Free Cash Flow Yield	0.03%	0.34%	0.30%	6.28%	2.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	20.61	26.42	22.83	10.98	10.09
Price-to-Sales (P/S) Ratio	2.65	3.83	3.29	1.58	1.26
Price-to-Book (P/B) Ratio	2.76	4.08	3.47	1.68	1.55
Price-to-Free Cash Flow (P/FCF) Ratio	3.72K	298.02	332.07	15.91	35.19
Price-to-Operating Cash Flow Ratio	98.75	48.66	31.09	12.32	18.76
Price-to-Earnings Growth (PEG) Ratio	8.43	1.24	2.87	0.26	-0.45
Price-to-Fair Value	2.76	4.08	3.47	1.68	1.55
Enterprise Value Multiple	12.63	18.69	13.76	6.69	5.41
Enterprise Value	72.81B	98.83B	70.03B	26.65B	16.27B
EV to EBITDA	12.63	18.69	13.76	6.69	5.41
EV to Sales	2.60	3.77	3.22	1.44	1.10
EV to Free Cash Flow	3.65K	292.87	324.69	14.50	30.74
EV to Operating Cash Flow	96.84	47.82	30.40	11.22	16.39
Tangible Book Value Per Share	56.89	52.44	43.71	39.86	27.71
Shareholders’ Equity Per Share	59.36	54.45	45.55	42.01	29.37
Tax and Other Ratios
Effective Tax Rate	0.24	0.24	0.26	0.21	0.25
Revenue Per Share	61.91	57.89	48.03	44.59	36.16
Net Income Per Share	7.96	8.40	6.92	6.41	4.51
Tax Burden	0.76	0.76	0.74	0.79	0.75
Interest Burden	0.99	1.13	0.97	0.97	0.97
Research & Development to Revenue	0.03	0.00	0.01	<0.01	0.01
SG&A to Revenue	0.00	<0.01	<0.01	<0.01	0.02
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.18	0.54	0.73	0.70	0.40

Currency in INR